DarioHealth (DRIO) vs LENSAR (LNSR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
LENSAR (LNSR) has outperformed DarioHealth (DRIO) over the past year, losing 46.9% versus a loss of 63.0%. Over five years, LNSR leads with a -15.3% price change compared with -98.2% for DRIO. LENSAR is the larger company by market cap ($78.3 million vs $56.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRIO | LNSR |
|---|---|---|
| Share price | $5.80 | $6.37 |
| Market cap | $56.84M | $78.26M |
| 1-day change | +4.69% | -1.24% |
| YTD return | -49.03% | -45.23% |
| 1-year return | -63.03% | -46.87% |
| 5-year return | -98.21% | -15.29% |
| P/E ratio (TTM) | — | 35.39 |
| EPS (TTM) | $-2.28 | $0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.50 | $12.94 |
| 52-week low | $5.37 | $4.95 |
| Distance from 52-week high | -64.85% | -50.77% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +134.48% | +77.86% |
| Average volume | 24.98K | 102.05K |
| Shares outstanding | 9.80M | 12.29M |
| Employees | 160 | 150 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LNSR has outperformed DRIO by 16.2 percentage points over the past year.
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Health Care · Medical/Dental Instruments · 160 employees
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
DRIO vs LNSR FAQ
Which is bigger, DarioHealth or LENSAR?
LENSAR (LNSR) is larger, with a market capitalization of $78.26M compared with $56.84M for DarioHealth (DRIO).
Which stock has performed better over the past year, DRIO or LNSR?
LNSR returned -46.87% over the past 12 months, compared with -63.03% for DRIO (price return, excluding dividends). Past performance does not predict future results.
Are DarioHealth and LENSAR in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.